DnB Asset Management’s Anavex Life Sciences AVXL Stock Holding History

DnB Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33,261	Closed	-$285K	–	725
2025 Q1	$285K	Buy	+33,261	New	+$314K	﹤0.01%	691

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

DnB Asset Management's AVXL Position: Q2 2025 in Review

DnB Asset Management sold out of Anavex Life Sciences (AVXL) in Q2 2025, closing a stake of 33,261 shares — an estimated $285K sold.

DnB Asset Management first reported a position in AVXL in Q1 2025 and held it in 1 quarter. The position peaked at $285K in Q1 2025. 178 funds tracked by Wall St. Rank hold AVXL as of Q2 2025.

DnB Asset Management reported no remaining Anavex Life Sciences position as of Q2 2025 after selling out during the quarter.
DnB Asset Management sold 33,261 Anavex Life Sciences shares in Q2 2025, an estimated $285K.
DnB Asset Management first reported a position in Anavex Life Sciences in Q1 2025 and held it in 1 quarter.
DnB Asset Management's Anavex Life Sciences position peaked at $285K in Q1 2025.
178 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2025.

Based on DnB Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.